Page last updated: 2024-09-05

tak 779 and rs 504393

tak 779 has been researched along with rs 504393 in 1 studies

Compound Research Comparison

Studies
(tak 779)
Trials
(tak 779)
Recent Studies (post-2010)
(tak 779)
Studies
(rs 504393)
Trials
(rs 504393)
Recent Studies (post-2010) (rs 504393)
11813532029

Protein Interaction Comparison

ProteinTaxonomytak 779 (IC50)rs 504393 (IC50)
C-C chemokine receptor type 2Homo sapiens (human)0.089

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkhout, TA; Blaney, FE; Bridges, AM; Cooper, DG; Forbes, IT; Gribble, AD; Groot, PH; Hardy, A; Ife, RJ; Kaur, R; Moores, KE; Shillito, H; Willetts, J; Witherington, J1

Other Studies

1 other study(ies) available for tak 779 and rs 504393

ArticleYear
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
    Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

    Topics: Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; Cattle; Cell Line; Chemotaxis; CHO Cells; Cricetinae; Humans; Indoles; Kinetics; Models, Molecular; Monocytes; Mutagenesis, Site-Directed; Piperidines; Radioligand Assay; Receptors, CCR2; Receptors, Chemokine; Recombinant Proteins; Rhodopsin; Structural Homology, Protein; Transfection

2003